Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05521607 · ClinicalTrials.gov registry record · NA
Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)
A NA study of Neonatal Jaundice, sponsored by Picterus AS.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT05521607 is a NA study of Neonatal Jaundice that is actively recruiting participants, run by Picterus AS. The registered enrollment target is 250 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05521607, a NA study of Neonatal Jaundice, is actively recruiting participants, sponsored by Picterus AS.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.
Conditions Studied
Interventions
- DEVICE Picterus Jaundice Pro (JP)
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-01-06 |
| Est. Completion | 2025-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05521607
The ClinicalTrials.gov registry entry for NCT05521607 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Picterus AS, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neonatal Jaundice appearing as the primary indexed condition, and to 1 intervention - of which Picterus Jaundice Pro (JP) is the first listed.
NCT05521607 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05521607 about?
NCT05521607 is a clinical study titled "Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)". A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.
What is the current status of trial NCT05521607?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-01-06. Estimated completion is 2025-06-15.
What conditions does trial NCT05521607 study?
This clinical trial studies the following conditions: Neonatal Jaundice.
What interventions are being tested in trial NCT05521607?
The interventions under investigation include: Picterus Jaundice Pro (JP) (DEVICE).
Who is sponsoring clinical trial NCT05521607?
This trial is sponsored by Picterus AS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05521607 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Jaundice
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.